Literature DB >> 18521538

Nitric oxide-induced headache may arise from extracerebral arteries as judged from tolerance to isosorbide-5-mononitrate.

Ingelise Christiansen1, Helle K Iversen, Jes Olesen, Peer Tfelt-Hansen.   

Abstract

Long-term exposure to organic nitrates influences different sections of the vascular bed heterogeneously. Continuous dosage of nitrates leads to the development of tolerance both to the vascular effects and to the unwanted adverse effect, headache. Human data on the development of tolerance in different cranial arteries over more than 24 h are lacking. We compared the vascular changes of the middle cerebral, superficial temporal and radial arteries during oral administration of isosorbide-5-mononitrate (5-ISMN) 30 mg three times daily for 7 days in 11 healthy subjects in a double-blind, randomised, placebo controlled cross-over design. Blood velocity in the middle cerebral artery was measured with transcranial Doppler and the diameters of the temporal and radial arteries were measured with high frequency ultrasound. Headache recordings were compared to the observed vascular changes over time. Tolerance was complete within 24 h in the middle cerebral artery whilst in the superficial temporal and the radial arteries, tolerance was only partial and developed much more slowly, i.e. after 7 days correlating with the disappearance of NO-induced headache. The present study thus demonstrated the important differences in the time profiles of appearance of nitrate tolerance in arteries of different vascular beds in man. If vasodilatation is the cause of NO-induced headache the results point to extracerebral arteries as the locus of nociception. Due to a variety of other possible pain-inducing effects of nitric oxide our results do not exclude cerebral arteries.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18521538      PMCID: PMC3451949          DOI: 10.1007/s10194-008-0043-9

Source DB:  PubMed          Journal:  J Headache Pain        ISSN: 1129-2369            Impact factor:   7.277


  40 in total

1.  Differential effects of pentaerythritol tetranitrate and nitroglycerin on the development of tolerance and evidence of lipid peroxidation: a human in vivo study.

Authors:  U Jurt; T Gori; A Ravandi; S Babaei; P Zeman; J D Parker
Journal:  J Am Coll Cardiol       Date:  2001-09       Impact factor: 24.094

2.  Brain blood flow in the nitroglycerin (GTN) model of migraine: measurement using positron emission tomography and transcranial Doppler.

Authors:  E M Bednarczyk; D S Wack; M Y Kassab; K Burch; K Trinidad; M Haka; J Gona
Journal:  Cephalalgia       Date:  2002-11       Impact factor: 6.292

Review 3.  Explaining the phenomenon of nitrate tolerance.

Authors:  Thomas Münzel; Andreas Daiber; Alexander Mülsch
Journal:  Circ Res       Date:  2005-09-30       Impact factor: 17.367

4.  Magnetic resonance angiography of the human middle meningeal artery: implications for migraine.

Authors:  Guus G Schoonman; Dick Bakker; Nicole Schmitz; Rob J van der Geest; Jeroen van der Grond; Michael D Ferrari; Mark A van Buchem
Journal:  J Magn Reson Imaging       Date:  2006-10       Impact factor: 4.813

5.  The effect of the nitric oxide donor glyceryl trinitrate on global and regional cerebral blood flow in man.

Authors:  R P White; C Deane; C Hindley; P M Bloomfield; V J Cunningham; P Vallance; D J Brooks; H S Markus
Journal:  J Neurol Sci       Date:  2000-09-01       Impact factor: 3.181

6.  Headache characteristics during the development of tolerance to nitrates: pathophysiological implications.

Authors:  I Christiansen; H K Iversen; J Olesen
Journal:  Cephalalgia       Date:  2000-06       Impact factor: 6.292

7.  Increased superoxide production in nitrate tolerance is associated with NAD(P)H oxidase and aldehyde dehydrogenase 2 downregulation.

Authors:  Katalin Szöcs; Bernard Lassègue; Philip Wenzel; Maria Wendt; Andreas Daiber; Matthias Oelze; Thomas Meinertz; Thomas Münzel; Stephan Baldus
Journal:  J Mol Cell Cardiol       Date:  2007-03-30       Impact factor: 5.000

8.  Oxidative inhibition of the mitochondrial aldehyde dehydrogenase promotes nitroglycerin tolerance in human blood vessels.

Authors:  Ulrich Hink; Andreas Daiber; Nalan Kayhan; Jordis Trischler; Catharina Kraatz; Matthias Oelze; Hanke Mollnau; Philip Wenzel; Christian F Vahl; Kwok Ki Ho; Henry Weiner; Thomas Munzel
Journal:  J Am Coll Cardiol       Date:  2007-11-19       Impact factor: 24.094

9.  Intracranial hemodynamics during intravenous infusion of glyceryl trinitrate.

Authors:  H K Iversen; S Holm; L Friberg; P Tfelt-Hansen
Journal:  J Headache Pain       Date:  2008-04-10       Impact factor: 7.277

10.  Decrease in endogenous CGRP release in nitroglycerin tolerance: role of ALDH-2.

Authors:  Yue-Rong Chen; Sheng-Dan Nie; Wang Shan; De-Jian Jiang; Rui-Zheng Shi; Zhi Zhou; Ren Guo; Zhe Zhang; Yuan-Jian Li
Journal:  Eur J Pharmacol       Date:  2007-06-05       Impact factor: 4.432

View more
  7 in total

Review 1.  Chemical mediators of migraine: preclinical and clinical observations.

Authors:  Saurabh Gupta; Stephanie J Nahas; B Lee Peterlin
Journal:  Headache       Date:  2011-06       Impact factor: 5.887

Review 2.  Headache-type adverse effects of NO donors: vasodilation and beyond.

Authors:  G Bagdy; P Riba; V Kecskeméti; D Chase; G Juhász
Journal:  Br J Pharmacol       Date:  2010-03-19       Impact factor: 8.739

3.  Sodium MRI in a rat migraine model and a NEURON simulation study support a role for sodium in migraine.

Authors:  Michael G Harrington; Eduard Y Chekmenev; Victor Schepkin; Alfred N Fonteh; Xianghong Arakaki
Journal:  Cephalalgia       Date:  2011-08-04       Impact factor: 6.292

4.  No effect of pure oxygen inhalation on headache induced by glyceryl trinitrate.

Authors:  Dorthe Daugaard; Peer Tfelt-Hansen; Lars Lykke Thomsen; Helle Klingenberg Iversen; Jes Olesen
Journal:  J Headache Pain       Date:  2010-02-09       Impact factor: 7.277

Review 5.  Future drugs for migraine.

Authors:  Ivano Farinelli; Sergio De Filippis; Gabriella Coloprisco; Serena Missori; Paolo Martelletti
Journal:  Intern Emerg Med       Date:  2009-06-24       Impact factor: 3.397

6.  Assessment Of Spanlastic Vesicles Of Zolmitriptan For Treating Migraine In Rats.

Authors:  Nagla Ahmed El-Nabarawy; Mahmoud Hassan Teaima; Doaa Ahmed Helal
Journal:  Drug Des Devel Ther       Date:  2019-11-21       Impact factor: 4.162

7.  Relationship between nitrate headache and outcome in patients with acute stroke: results from the efficacy of nitric oxide in stroke (ENOS) trial.

Authors:  Lucy Beishon; Lisa J Woodhouse; Daniel Bereczki; Hanne K Christensen; Ronan Collins; John Gommans; Christina Kruuse; George Ntaios; Serefnur Ozturk; Stephen Phillips; Stuart Pocock; Szabolcs Szatmari; Joanna Wardlaw; Nikola Sprigg; Philip M Bath
Journal:  Stroke Vasc Neurol       Date:  2020-11-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.